FOLH1 and renal cell carcinoma: Two of the included studies on 19 patients with metastatic RCC (all ccRCC subtype) evaluated the utility of an 18F-based PSMA radiotracer (18F-DCFPyL) and provided a direct comparison with conventional imaging (17,19).